EFFICACY, SATISFACTION, AND DISCOMFORT OF LONG ACTING CONTRACEPTIVE METHODS IN SULAIMANI CITY, IRAQ: A COMPARATIVE FOLLOW UP STUDY
Keywords:Mesne discomfort, Mirena, Implanon, Long Acting Contraception
The choice of available contraceptive methods has increased in recent years At the same time, women’s awareness of methods and reasons for their method choice, or reasons for changing methods, is limited. Long-acting reversible contraception (LARC ) in the form of intrauterine devices (IUDs) and the subdermal implant are starting to use.
The aim of this study was to assess the efficacy, satisfaction, and discomfort of two common types of long acting contraceptive methods in Sulaimani City.
Patients and Methods
The study was a comparative follow up study, 80 non pregnant married women at reproductive age were included. Verbal consent was taken from the lady to use one of the methods. Patients were allocated into two groups, 40 were using long acting reversible contraception LARC (Intrauterine levonegesterl loaded system “Mirena”, while the others 40 patients used subdermal progestene “Implanon”. Insertion of both methods were performed by the researcher by following the scientific guides and techniques.
Mean age of patients with Implanon use was nearly 30 years old, while for those using Mirena was 34.5; this difference statistically was highly significant. Highest level of satisfaction (65%) was reported among women using Mirena, while high percentage of dissatisfaction was reported among women who were using Implanon, this association statistically was highly significant.
Highest level of satisfaction, decrease in duration of blood flow, and discomfort during insertion were reported among women were using Mirena, Generally there are significant reduction in heavy blood flow, and presence of dysmmenrohea one year after insertion of both types of long acting contraception.
-Long-acting reversible contraception Clinical guideline Published: 26 October 2005 nice.org.uk/guidance/cg30 .
- Gina M., Jenifer E., Tessa M., Jennifer L., and Jeffrey F. The Contraceptive CHOICE Project: Reducing Barriers to Long- Acting Reversible Contraception. . Am J Obstet Gynecol. 2010 August ; 203(2): 115.e1–115.e7. doi:10.1016/j.ajog.2010.04.017.
- Kari W., Hopkins K., Potter J.E, and Grossman D. Knowledge and attitudes about long-acting reversible contraception among Latina women who desire sterilization. Womens Health Issues. 2013 Jul-Aug; 23(4): e257–e263.
- Power J, French R, Cowan F. Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods for preventing pregnancy. Cochrane Database of Systematic Reviews. 2008 . Trussell J. Contraceptive failure in the United States. Contraception. 2011; 83:397–404. [PubMed: 21477680]).
- Jakimikuk J., Crosignan P., Chernev T., Prilepskaya V., Bergmans P., et al: High levels of women’s satisfaction and compliance with transdermal contraception: results from a European multinational, 6-month study. Gynecol Endocrinol. 2011 Oct; 27(10): 849–856.
- Renee E., Kenerson J., and Jeffrey F. Reversible Contraception Update: The Importance of Long-Acting Reversible Contraception. Postgrad Med. 2009 July ; 121(4): 18–25. doi:10.3810/pgm.2009.07.2025.
Mestad R., Secura G., Jenifer E., Tessa M., Qiuhong Z., and Jeffrey F . Acceptance of long-acting reversible contraceptive methods by adolescent participants in the Contraceptive CHOICE Project; Contraception. 2011 November ; 84(5): 493–498. doi:10.1016/j.contraception.2011.03.001.
Li CFI, Lee SSN, Pun TC. A pilot study on the acceptability of levonorgestrel-releasing intrauterine device by young, single, nullip-arous Chinese females following surgical abortion. Contraception. 2004; 69:247–250. [PubMed: 14969674]
- Darney P, Patel A, Rosen K, et al. Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials. Fertil Steril. 2009; 91(5):1646–53. [PubMed: 18423453]
Mansour D, Korver T, Marintcheva-Petrova M. The effects of Implanon on menstrual bleeding patterns. Eur J Contracept Reprod Health Care. 2008; 13(Suppl. 1):13–28. [PubMed: 18330814]
: Peipert J., Zhao Q., Jenifer E. , Petrosky E., Madden T., Eisenberg D. et al. Continuation and Satisfaction of Reversible Contraception: Published in final edited form as: Obstet Gynecol. 2011 May ; 117(5): 1105–1113. doi:10.1097/AOG.0b013e31821188ad.
Stoddard A., McNicholas C., and Jeffrey F. Efficacy and Safety of Long-Acting Reversible Contraception: Published in final edited form as: Drugs. 2011 May 28; 71(8): 969–980..
Andersson JK, Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynaecol. 1990; 97(8):690–4. [PubMed: 2119218]
Hidalgo M, Bahamondes L, Perrotti M. Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years. Contraception. 2002; 65(2): 129–32. [PubMed: 11927115]
Jindabanjerd K, Taneepanichskul S. The use of levonorgestrel-IUD in the treatment of uterine myoma in Thai women. J Med Assoc Thai. 2006; 89(Suppl. 4):S147–51. [PubMed: 17726816]
Zapata LB, Whiteman MK, Tepper NK,. Intrauterine device use among women with uterine fibroids: a systematic review. Contraception. 2010; 82(1):41–55. [PubMed: 20682142]
Funk S, Miller MM, Mishell DR Jr,. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Contraception. 2005; 71(5):319–26. [PubMed: 15854630]
Ponpuckdee J, Taneepanichskul S. The effects of implanon in the symptomatic treatment of endometriosis. J Med Assoc Thai. 2005; 88(Suppl. 2):S7–10. [PubMed: 17722311]
Mansour D, Korver T, Marintcheva-Petrova M, et al. The effects of Implanon on menstrual bleeding patterns. Eur J Contracept Reprod Health Care. 2008; 13(Suppl. 1):13–28. [PubMed: 18330814]
Copyright (c) 2020 Abeer Muhyadden Saeed, Huda Muhaddein Mohammed and Fattah Hama Rahim Fattah
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.